Supernus Pharmaceuticals | SUPN - Action





Action Changement Date
Abbott USD 6.49B 220M 2025-12
ANI Pharmaceuticals USD 143.07M 3.41M 2025-12
Aurora Cannabis CAD 230.56M 8.6M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Canopy Growth CAD 105.56M 3.18M 2025-12
Cara Therapeutics USD 900K 0 2025-03
Corcept Therapeutics USD 12.87M 519K 2025-12
Eisai JPY 236.46B 9.14B 2025-09
Eli Lilly USD 13.74B 1.56B 2025-12
Novo Nordisk DKK 45.65B 21.26B 2025-06
Pacira USD 152.86M 4.82M 2025-12
Perrigo USD 1.15B 78M 2025-12
Pfizer USD 11.47B 201M 2025-09
Supernus Pharmaceuticals USD 107.1M 63.08M 2025-09
United Therapeutics USD 183.1M 6.6M 2025-12
Xeris Pharmaceuticals USD 68.67M 1.21M 2025-12